| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9951229 | European Journal of Vascular and Endovascular Surgery | 2005 | 6 Pages |
Abstract
The dual anti-platelet regime has a significant impact on reducing adverse neurological outcomes without an additional increase in bleeding complications. This study was terminated prematurely due to an unacceptable level of complications in the heparin arm of the trial.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
F.M. McKevitt, M.S. Randall, T.J. Cleveland, P.A. Gaines, K.T. Tan, G.S. Venables,